Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenbin Gu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Medical Sciences|July 7, 2020
Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung AdenocarcinomaZhijun Han, Yangyang Li, Jian Zhang, et al.
Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.
Nature Communications|January 8, 2025
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapyWenjing Bai, Jinxin Xu, Wenbin Gu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Medical Sciences|July 7, 2020
Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung AdenocarcinomaZhijun Han, Yangyang Li, Jian Zhang, et al.
Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.
Nature Communications|January 8, 2025
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapyWenjing Bai, Jinxin Xu, Wenbin Gu, et al.
Pageof 2